Found 8 matching trials
Comparative Bioavailability of Risperidone
PHASE1This is an open-label, one sequence study to evaluate the steady-state comp...
Location
Collaborative Neuroscience Network
Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse
N/AThis is a prospective, non-interventional, multicentre study designed to co...
Location
Investigational site number DE-06
Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths
PHASE1This clinical trial is designed to evaluate different dosages of risperidon...
Location
Multiple Locations
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
PHASE3This is the long-term open label extension (OLE) of the study PRISMA-3 (NCT...
Location
Woodland Research Northwest
Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia
PHASE2To characterize the pharmacokinetics (PK) of the injectable intramuscular (...
Location
St Louis Clinical Trials, LC
Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute Schizophrenia
PHASE3This is a multicenter, randomized, double-blind, placebo-controlled study d...
Location
Woodland Research Northwest
Comparative Bioavailability of Risperidone.
PHASE1This is an Open-Label, One-Sequence Study to Evaluate the Steady- State Com...
Location
Collaborative NeuroScience Research, LLC
Pharmacokinetics, Safety, and Tolerance Study of Single Dose Administration of Risperidone ISM®
PHASE1The study will comprise two dosing periods in two different cohorts of heal...
Location
Multiple Locations